{"altmetric_id":15776010,"counts":{"readers":{"mendeley":1,"citeulike":0,"connotea":0},"total":{"posts_count":1},"policy":{"unique_users_count":1,"unique_users":["nice"],"posts_count":1}},"citation":{"altmetric_jid":"4f6fa6103cf058f610006db3","authors":["Sch\u00f6lmerich, J\u00fcrgen","Jenss, Harro","Hartmann, Franz","D\u00f6pfer, Hanne","The German 5-ASA Study Group, "],"doi":"10.1155\/1990\/260563","endpage":"451","first_seen_on":"2017-01-25T14:01:00+00:00","issns":["0835-7900"],"issue":"7","journal":"The Canadian Journal of Gastroenterology","last_mentioned_on":1349827200,"links":["http:\/\/dx.doi.org\/10.1155\/1990\/260563"],"pdf_url":"http:\/\/downloads.hindawi.com\/journals\/cjgh\/1990\/260563.pdf","pubdate":"1990-01-01T00:00:00+00:00","publisher":"Hindawi Publishing Corporation","publisher_subjects":[{"name":"Clinical Sciences","scheme":"era"}],"scopus_subjects":["Medicine","Health Sciences"],"startpage":"446","title":"Oral 5-Aminosalicyclic Acid Versus 6-Methylprednisolone in Active Crohn's Disease","type":"article","uri":"http:\/\/www.hindawi.com\/journals\/cjgh\/1990\/260563\/abs\/","volume":"4","mendeley_url":"http:\/\/www.mendeley.com\/research\/oral-5aminosalicyclic-acid-versus-6methylprednisolone-active-crohns-disease"},"altmetric_score":{"score":3,"score_history":{"1y":0,"6m":0,"3m":0,"1m":0,"1w":0,"6d":0,"5d":0,"4d":0,"3d":0,"2d":0,"1d":0,"at":3},"context_for_score":{"all":{"total_number_of_other_articles":7027828,"mean":6.2647750304584,"rank":1649605,"this_scored_higher_than_pct":64,"this_scored_higher_than":4555779,"rank_type":"exact","sample_size":7027828,"percentile":64},"similar_age_3m":{"total_number_of_other_articles":88702,"mean":11.129855875357,"rank":26912,"this_scored_higher_than_pct":67,"this_scored_higher_than":60234,"rank_type":"exact","sample_size":88702,"percentile":67},"this_journal":{"total_number_of_other_articles":233,"mean":3.1922931034483,"rank":49,"this_scored_higher_than_pct":65,"this_scored_higher_than":152,"rank_type":"exact","sample_size":233,"percentile":65},"similar_age_this_journal_3m":{"total_number_of_other_articles":1,"mean":0,"rank":1,"this_scored_higher_than_pct":1,"this_scored_higher_than":0,"rank_type":"exact","sample_size":1,"percentile":1}}},"demographics":{"users":{"mendeley":{"by_status":{"Student  > Master":1},"by_discipline":{"Medicine and Dentistry":1}}}},"posts":{"policy":[{"title":"Crohn's disease: management: Appendix H - Health economics report","url":"https:\/\/www.nice.org.uk\/guidance\/cg152\/evidence\/appendix-h-health-economics-report-248633685","license":"public","citation_ids":[2601872,639734,15785440,15775992,15775996,2432124,15776003,15775986,15776010,15776013,15775988,15776018,15776019,3389994,15776020,15776022,15776024,15775991,15776025,3378263,2432161,4630611,3215018,15776027,15776031,14721707,5349308,231261,2432152,15776035,4323582,15776037,15776044,15776048],"posted_on":"2012-10-10T00:00:00+00:00","source":{"name":"National Institute for Health and Care Excellence","description":"The National Institute for Health and Care Excellence (NICE) in the UK provides national guidance and advice to improve health and social care.","geo":{"country":"GB"}},"page_url":"https:\/\/www.nice.org.uk\/guidance\/cg152\/evidence","collections":[],"author":{"image":"https:\/\/s3.amazonaws.com\/cache.altmetric.com\/policy\/thumbnails\/thumbnail-ee633f8c0594ffd25383fffc1fa170181ba143b3f0b2ce5d88d9f26aff9d5803.jpg"}}]}}